Global Bioengineered Protein Drugs Market Growth 2025-2031

October 2025 | 116 pages | ID: G7CE4D4BCFB7EN
LP Information

Abstracts

The global Bioengineered Protein Drugs market size is predicted to grow from US$ 91830 million in 2025 to US$ 117380 million in 2031; it is expected to grow at a CAGR of 4.2% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the ?Bioengineered Protein Drugs Industry Forecast? looks at past sales and reviews total world Bioengineered Protein Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Bioengineered Protein Drugs sales for 2025 through 2031. With Bioengineered Protein Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bioengineered Protein Drugs industry.

This Insight Report provides a comprehensive analysis of the global Bioengineered Protein Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bioengineered Protein Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Bioengineered Protein Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bioengineered Protein Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bioengineered Protein Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Bioengineered Protein Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Monoclonal Antibodies
• Therapeutic Proteins
• Vaccines

Segmentation by Application:

• Cancer
• Diabetes
• Autoimmune Disorder
• Infectious Disease
• Neurodegenerative
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Dr.Reddy?s
• Eli Lilly
• Merck
• Reliance Life Sciences
• Panacea Biotech
• Novartis
• Fresenius
• Sanofi
• ProBioGen
• GlaxoSmithKline
• Roche
• Amoytop Biotech
• Shanghai United Cell Biotechnology
• Hualan Bio

Key Questions Addressed in this Report

What is the 10-year outlook for the global Bioengineered Protein Drugs market?
What factors are driving Bioengineered Protein Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bioengineered Protein Drugs market opportunities vary by end market size?
How does Bioengineered Protein Drugs break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Bioengineered Protein Drugs Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Bioengineered Protein Drugs by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Bioengineered Protein Drugs by Country/Region, 2020, 2024 & 2031
2.2 Bioengineered Protein Drugs Segment by Type
  2.2.1 Monoclonal Antibodies
  2.2.2 Therapeutic Proteins
  2.2.3 Vaccines
2.3 Bioengineered Protein Drugs Sales by Type
  2.3.1 Global Bioengineered Protein Drugs Sales Market Share by Type (2020-2025)
  2.3.2 Global Bioengineered Protein Drugs Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Bioengineered Protein Drugs Sale Price by Type (2020-2025)
2.4 Bioengineered Protein Drugs Segment by Application
  2.4.1 Cancer
  2.4.2 Diabetes
  2.4.3 Autoimmune Disorder
  2.4.4 Infectious Disease
  2.4.5 Neurodegenerative
  2.4.6 Others
2.5 Bioengineered Protein Drugs Sales by Application
  2.5.1 Global Bioengineered Protein Drugs Sale Market Share by Application (2020-2025)
  2.5.2 Global Bioengineered Protein Drugs Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Bioengineered Protein Drugs Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Bioengineered Protein Drugs Breakdown Data by Company
  3.1.1 Global Bioengineered Protein Drugs Annual Sales by Company (2020-2025)
  3.1.2 Global Bioengineered Protein Drugs Sales Market Share by Company (2020-2025)
3.2 Global Bioengineered Protein Drugs Annual Revenue by Company (2020-2025)
  3.2.1 Global Bioengineered Protein Drugs Revenue by Company (2020-2025)
  3.2.2 Global Bioengineered Protein Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Bioengineered Protein Drugs Sale Price by Company
3.4 Key Manufacturers Bioengineered Protein Drugs Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Bioengineered Protein Drugs Product Location Distribution
  3.4.2 Players Bioengineered Protein Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR BIOENGINEERED PROTEIN DRUGS BY GEOGRAPHIC REGION

4.1 World Historic Bioengineered Protein Drugs Market Size by Geographic Region (2020-2025)
  4.1.1 Global Bioengineered Protein Drugs Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Bioengineered Protein Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Bioengineered Protein Drugs Market Size by Country/Region (2020-2025)
  4.2.1 Global Bioengineered Protein Drugs Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Bioengineered Protein Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bioengineered Protein Drugs Sales Growth
4.4 APAC Bioengineered Protein Drugs Sales Growth
4.5 Europe Bioengineered Protein Drugs Sales Growth
4.6 Middle East & Africa Bioengineered Protein Drugs Sales Growth

5 AMERICAS

5.1 Americas Bioengineered Protein Drugs Sales by Country
  5.1.1 Americas Bioengineered Protein Drugs Sales by Country (2020-2025)
  5.1.2 Americas Bioengineered Protein Drugs Revenue by Country (2020-2025)
5.2 Americas Bioengineered Protein Drugs Sales by Type (2020-2025)
5.3 Americas Bioengineered Protein Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Bioengineered Protein Drugs Sales by Region
  6.1.1 APAC Bioengineered Protein Drugs Sales by Region (2020-2025)
  6.1.2 APAC Bioengineered Protein Drugs Revenue by Region (2020-2025)
6.2 APAC Bioengineered Protein Drugs Sales by Type (2020-2025)
6.3 APAC Bioengineered Protein Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Bioengineered Protein Drugs by Country
  7.1.1 Europe Bioengineered Protein Drugs Sales by Country (2020-2025)
  7.1.2 Europe Bioengineered Protein Drugs Revenue by Country (2020-2025)
7.2 Europe Bioengineered Protein Drugs Sales by Type (2020-2025)
7.3 Europe Bioengineered Protein Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Bioengineered Protein Drugs by Country
  8.1.1 Middle East & Africa Bioengineered Protein Drugs Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Bioengineered Protein Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Bioengineered Protein Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Bioengineered Protein Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs
10.3 Manufacturing Process Analysis of Bioengineered Protein Drugs
10.4 Industry Chain Structure of Bioengineered Protein Drugs

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Bioengineered Protein Drugs Distributors
11.3 Bioengineered Protein Drugs Customer

12 WORLD FORECAST REVIEW FOR BIOENGINEERED PROTEIN DRUGS BY GEOGRAPHIC REGION

12.1 Global Bioengineered Protein Drugs Market Size Forecast by Region
  12.1.1 Global Bioengineered Protein Drugs Forecast by Region (2026-2031)
  12.1.2 Global Bioengineered Protein Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Bioengineered Protein Drugs Forecast by Type (2026-2031)
12.7 Global Bioengineered Protein Drugs Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Dr.Reddy?s
  13.1.1 Dr.Reddy?s Company Information
  13.1.2 Dr.Reddy?s Bioengineered Protein Drugs Product Portfolios and Specifications
  13.1.3 Dr.Reddy?s Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Dr.Reddy?s Main Business Overview
  13.1.5 Dr.Reddy?s Latest Developments
13.2 Eli Lilly
  13.2.1 Eli Lilly Company Information
  13.2.2 Eli Lilly Bioengineered Protein Drugs Product Portfolios and Specifications
  13.2.3 Eli Lilly Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Eli Lilly Main Business Overview
  13.2.5 Eli Lilly Latest Developments
13.3 Merck
  13.3.1 Merck Company Information
  13.3.2 Merck Bioengineered Protein Drugs Product Portfolios and Specifications
  13.3.3 Merck Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Merck Main Business Overview
  13.3.5 Merck Latest Developments
13.4 Reliance Life Sciences
  13.4.1 Reliance Life Sciences Company Information
  13.4.2 Reliance Life Sciences Bioengineered Protein Drugs Product Portfolios and Specifications
  13.4.3 Reliance Life Sciences Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Reliance Life Sciences Main Business Overview
  13.4.5 Reliance Life Sciences Latest Developments
13.5 Panacea Biotech
  13.5.1 Panacea Biotech Company Information
  13.5.2 Panacea Biotech Bioengineered Protein Drugs Product Portfolios and Specifications
  13.5.3 Panacea Biotech Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Panacea Biotech Main Business Overview
  13.5.5 Panacea Biotech Latest Developments
13.6 Novartis
  13.6.1 Novartis Company Information
  13.6.2 Novartis Bioengineered Protein Drugs Product Portfolios and Specifications
  13.6.3 Novartis Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Novartis Main Business Overview
  13.6.5 Novartis Latest Developments
13.7 Fresenius
  13.7.1 Fresenius Company Information
  13.7.2 Fresenius Bioengineered Protein Drugs Product Portfolios and Specifications
  13.7.3 Fresenius Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Fresenius Main Business Overview
  13.7.5 Fresenius Latest Developments
13.8 Sanofi
  13.8.1 Sanofi Company Information
  13.8.2 Sanofi Bioengineered Protein Drugs Product Portfolios and Specifications
  13.8.3 Sanofi Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Sanofi Main Business Overview
  13.8.5 Sanofi Latest Developments
13.9 ProBioGen
  13.9.1 ProBioGen Company Information
  13.9.2 ProBioGen Bioengineered Protein Drugs Product Portfolios and Specifications
  13.9.3 ProBioGen Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 ProBioGen Main Business Overview
  13.9.5 ProBioGen Latest Developments
13.10 GlaxoSmithKline
  13.10.1 GlaxoSmithKline Company Information
  13.10.2 GlaxoSmithKline Bioengineered Protein Drugs Product Portfolios and Specifications
  13.10.3 GlaxoSmithKline Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 GlaxoSmithKline Main Business Overview
  13.10.5 GlaxoSmithKline Latest Developments
13.11 Roche
  13.11.1 Roche Company Information
  13.11.2 Roche Bioengineered Protein Drugs Product Portfolios and Specifications
  13.11.3 Roche Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 Roche Main Business Overview
  13.11.5 Roche Latest Developments
13.12 Amoytop Biotech
  13.12.1 Amoytop Biotech Company Information
  13.12.2 Amoytop Biotech Bioengineered Protein Drugs Product Portfolios and Specifications
  13.12.3 Amoytop Biotech Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.12.4 Amoytop Biotech Main Business Overview
  13.12.5 Amoytop Biotech Latest Developments
13.13 Shanghai United Cell Biotechnology
  13.13.1 Shanghai United Cell Biotechnology Company Information
  13.13.2 Shanghai United Cell Biotechnology Bioengineered Protein Drugs Product Portfolios and Specifications
  13.13.3 Shanghai United Cell Biotechnology Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.13.4 Shanghai United Cell Biotechnology Main Business Overview
  13.13.5 Shanghai United Cell Biotechnology Latest Developments
13.14 Hualan Bio
  13.14.1 Hualan Bio Company Information
  13.14.2 Hualan Bio Bioengineered Protein Drugs Product Portfolios and Specifications
  13.14.3 Hualan Bio Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.14.4 Hualan Bio Main Business Overview
  13.14.5 Hualan Bio Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Bioengineered Protein Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Bioengineered Protein Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Therapeutic Proteins
Table 5. Major Players of Vaccines
Table 6. Global Bioengineered Protein Drugs Sales by Type (2020-2025) & (Units)
Table 7. Global Bioengineered Protein Drugs Sales Market Share by Type (2020-2025)
Table 8. Global Bioengineered Protein Drugs Revenue by Type (2020-2025) & ($ million)
Table 9. Global Bioengineered Protein Drugs Revenue Market Share by Type (2020-2025)
Table 10. Global Bioengineered Protein Drugs Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global Bioengineered Protein Drugs Sale by Application (2020-2025) & (Units)
Table 12. Global Bioengineered Protein Drugs Sale Market Share by Application (2020-2025)
Table 13. Global Bioengineered Protein Drugs Revenue by Application (2020-2025) & ($ million)
Table 14. Global Bioengineered Protein Drugs Revenue Market Share by Application (2020-2025)
Table 15. Global Bioengineered Protein Drugs Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Bioengineered Protein Drugs Sales by Company (2020-2025) & (Units)
Table 17. Global Bioengineered Protein Drugs Sales Market Share by Company (2020-2025)
Table 18. Global Bioengineered Protein Drugs Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Bioengineered Protein Drugs Revenue Market Share by Company (2020-2025)
Table 20. Global Bioengineered Protein Drugs Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Bioengineered Protein Drugs Producing Area Distribution and Sales Area
Table 22. Players Bioengineered Protein Drugs Products Offered
Table 23. Bioengineered Protein Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Bioengineered Protein Drugs Sales by Geographic Region (2020-2025) & (Units)
Table 27. Global Bioengineered Protein Drugs Sales Market Share Geographic Region (2020-2025)
Table 28. Global Bioengineered Protein Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Bioengineered Protein Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Bioengineered Protein Drugs Sales by Country/Region (2020-2025) & (Units)
Table 31. Global Bioengineered Protein Drugs Sales Market Share by Country/Region (2020-2025)
Table 32. Global Bioengineered Protein Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Bioengineered Protein Drugs Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Bioengineered Protein Drugs Sales by Country (2020-2025) & (Units)
Table 35. Americas Bioengineered Protein Drugs Sales Market Share by Country (2020-2025)
Table 36. Americas Bioengineered Protein Drugs Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Bioengineered Protein Drugs Sales by Type (2020-2025) & (Units)
Table 38. Americas Bioengineered Protein Drugs Sales by Application (2020-2025) & (Units)
Table 39. APAC Bioengineered Protein Drugs Sales by Region (2020-2025) & (Units)
Table 40. APAC Bioengineered Protein Drugs Sales Market Share by Region (2020-2025)
Table 41. APAC Bioengineered Protein Drugs Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Bioengineered Protein Drugs Sales by Type (2020-2025) & (Units)
Table 43. APAC Bioengineered Protein Drugs Sales by Application (2020-2025) & (Units)
Table 44. Europe Bioengineered Protein Drugs Sales by Country (2020-2025) & (Units)
Table 45. Europe Bioengineered Protein Drugs Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Bioengineered Protein Drugs Sales by Type (2020-2025) & (Units)
Table 47. Europe Bioengineered Protein Drugs Sales by Application (2020-2025) & (Units)
Table 48. Middle East & Africa Bioengineered Protein Drugs Sales by Country (2020-2025) & (Units)
Table 49. Middle East & Africa Bioengineered Protein Drugs Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Bioengineered Protein Drugs Sales by Type (2020-2025) & (Units)
Table 51. Middle East & Africa Bioengineered Protein Drugs Sales by Application (2020-2025) & (Units)
Table 52. Key Market Drivers & Growth Opportunities of Bioengineered Protein Drugs
Table 53. Key Market Challenges & Risks of Bioengineered Protein Drugs
Table 54. Key Industry Trends of Bioengineered Protein Drugs
Table 55. Bioengineered Protein Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Bioengineered Protein Drugs Distributors List
Table 58. Bioengineered Protein Drugs Customer List
Table 59. Global Bioengineered Protein Drugs Sales Forecast by Region (2026-2031) & (Units)
Table 60. Global Bioengineered Protein Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Bioengineered Protein Drugs Sales Forecast by Country (2026-2031) & (Units)
Table 62. Americas Bioengineered Protein Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Bioengineered Protein Drugs Sales Forecast by Region (2026-2031) & (Units)
Table 64. APAC Bioengineered Protein Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Bioengineered Protein Drugs Sales Forecast by Country (2026-2031) & (Units)
Table 66. Europe Bioengineered Protein Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Bioengineered Protein Drugs Sales Forecast by Country (2026-2031) & (Units)
Table 68. Middle East & Africa Bioengineered Protein Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Bioengineered Protein Drugs Sales Forecast by Type (2026-2031) & (Units)
Table 70. Global Bioengineered Protein Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Bioengineered Protein Drugs Sales Forecast by Application (2026-2031) & (Units)
Table 72. Global Bioengineered Protein Drugs Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Dr.Reddy?s Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Dr.Reddy?s Bioengineered Protein Drugs Product Portfolios and Specifications
Table 75. Dr.Reddy?s Bioengineered Protein Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Dr.Reddy?s Main Business
Table 77. Dr.Reddy?s Latest Developments
Table 78. Eli Lilly Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Eli Lilly Bioengineered Protein Drugs Product Portfolios and Specifications
Table 80. Eli Lilly Bioengineered Protein Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Eli Lilly Main Business
Table 82. Eli Lilly Latest Developments
Table 83. Merck Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck Bioengineered Protein Drugs Product Portfolios and Specifications
Table 85. Merck Bioengineered Protein Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. Reliance Life Sciences Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Reliance Life Sciences Bioengineered Protein Drugs Product Portfolios and Specifications
Table 90. Reliance Life Sciences Bioengineered Protein Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Reliance Life Sciences Main Business
Table 92. Reliance Life Sciences Latest Developments
Table 93. Panacea Biotech Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Panacea Biotech Bioengineered Protein Drugs Product Portfolios and Specifications
Table 95. Panacea Biotech Bioengineered Protein Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Panacea Biotech Main Business
Table 97. Panacea Biotech Latest Developments
Table 98. Novartis Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Novartis Bioengineered Protein Drugs Product Portfolios and Specifications
Table 100. Novartis Bioengineered Protein Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Novartis Main Business
Table 102. Novartis Latest Developments
Table 103. Fresenius Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Fresenius Bioengineered Protein Drugs Product Portfolios and Specifications
Table 105. Fresenius Bioengineered Protein Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Fresenius Main Business
Table 107. Fresenius Latest Developments
Table 108. Sanofi Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Sanofi Bioengineered Protein Drugs Product Portfolios and Specifications
Table 110. Sanofi Bioengineered Protein Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Sanofi Main Business
Table 112. Sanofi Latest Developments
Table 113. ProBioGen Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. ProBioGen Bioengineered Protein Drugs Product Portfolios and Specifications
Table 115. ProBioGen Bioengineered Protein Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. ProBioGen Main Business
Table 117. ProBioGen Latest Developments
Table 118. GlaxoSmithKline Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. GlaxoSmithKline Bioengineered Protein Drugs Product Portfolios and Specifications
Table 120. GlaxoSmithKline Bioengineered Protein Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. GlaxoSmithKline Main Business
Table 122. GlaxoSmithKline Latest Developments
Table 123. Roche Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Roche Bioengineered Protein Drugs Product Portfolios and Specifications
Table 125. Roche Bioengineered Protein Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. Roche Main Business
Table 127. Roche Latest Developments
Table 128. Amoytop Biotech Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Amoytop Biotech Bioengineered Protein Drugs Product Portfolios and Specifications
Table 130. Amoytop Biotech Bioengineered Protein Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131. Amoytop Biotech Main Business
Table 132. Amoytop Biotech Latest Developments
Table 133. Shanghai United Cell Biotechnology Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. Shanghai United Cell Biotechnology Bioengineered Protein Drugs Product Portfolios and Specifications
Table 135. Shanghai United Cell Biotechnology Bioengineered Protein Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. Shanghai United Cell Biotechnology Main Business
Table 137. Shanghai United Cell Biotechnology Latest Developments
Table 138. Hualan Bio Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors
Table 139. Hualan Bio Bioengineered Protein Drugs Product Portfolios and Specifications
Table 140. Hualan Bio Bioengineered Protein Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 141. Hualan Bio Main Business
Table 142. Hualan Bio Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Bioengineered Protein Drugs
Figure 2. Bioengineered Protein Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bioengineered Protein Drugs Sales Growth Rate 2020-2031 (Units)
Figure 7. Global Bioengineered Protein Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Bioengineered Protein Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Bioengineered Protein Drugs Sales Market Share by Country/Region (2024)
Figure 10. Bioengineered Protein Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Monoclonal Antibodies
Figure 12. Product Picture of Therapeutic Proteins
Figure 13. Product Picture of Vaccines
Figure 14. Global Bioengineered Protein Drugs Sales Market Share by Type in 2025
Figure 15. Global Bioengineered Protein Drugs Revenue Market Share by Type (2020-2025)
Figure 16. Bioengineered Protein Drugs Consumed in Cancer
Figure 17. Global Bioengineered Protein Drugs Market: Cancer (2020-2025) & (Units)
Figure 18. Bioengineered Protein Drugs Consumed in Diabetes
Figure 19. Global Bioengineered Protein Drugs Market: Diabetes (2020-2025) & (Units)
Figure 20. Bioengineered Protein Drugs Consumed in Autoimmune Disorder
Figure 21. Global Bioengineered Protein Drugs Market: Autoimmune Disorder (2020-2025) & (Units)
Figure 22. Bioengineered Protein Drugs Consumed in Infectious Disease
Figure 23. Global Bioengineered Protein Drugs Market: Infectious Disease (2020-2025) & (Units)
Figure 24. Bioengineered Protein Drugs Consumed in Neurodegenerative
Figure 25. Global Bioengineered Protein Drugs Market: Neurodegenerative (2020-2025) & (Units)
Figure 26. Bioengineered Protein Drugs Consumed in Others
Figure 27. Global Bioengineered Protein Drugs Market: Others (2020-2025) & (Units)
Figure 28. Global Bioengineered Protein Drugs Sale Market Share by Application (2024)
Figure 29. Global Bioengineered Protein Drugs Revenue Market Share by Application in 2025
Figure 30. Bioengineered Protein Drugs Sales by Company in 2025 (Units)
Figure 31. Global Bioengineered Protein Drugs Sales Market Share by Company in 2025
Figure 32. Bioengineered Protein Drugs Revenue by Company in 2025 ($ millions)
Figure 33. Global Bioengineered Protein Drugs Revenue Market Share by Company in 2025
Figure 34. Global Bioengineered Protein Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 35. Global Bioengineered Protein Drugs Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Bioengineered Protein Drugs Sales 2020-2025 (Units)
Figure 37. Americas Bioengineered Protein Drugs Revenue 2020-2025 ($ millions)
Figure 38. APAC Bioengineered Protein Drugs Sales 2020-2025 (Units)
Figure 39. APAC Bioengineered Protein Drugs Revenue 2020-2025 ($ millions)
Figure 40. Europe Bioengineered Protein Drugs Sales 2020-2025 (Units)
Figure 41. Europe Bioengineered Protein Drugs Revenue 2020-2025 ($ millions)
Figure 42. Middle East & Africa Bioengineered Protein Drugs Sales 2020-2025 (Units)
Figure 43. Middle East & Africa Bioengineered Protein Drugs Revenue 2020-2025 ($ millions)
Figure 44. Americas Bioengineered Protein Drugs Sales Market Share by Country in 2025
Figure 45. Americas Bioengineered Protein Drugs Revenue Market Share by Country (2020-2025)
Figure 46. Americas Bioengineered Protein Drugs Sales Market Share by Type (2020-2025)
Figure 47. Americas Bioengineered Protein Drugs Sales Market Share by Application (2020-2025)
Figure 48. United States Bioengineered Protein Drugs Revenue Growth 2020-2025 ($ millions)
Figure 49. Canada Bioengineered Protein Drugs Revenue Growth 2020-2025 ($ millions)
Figure 50. Mexico Bioengineered Protein Drugs Revenue Growth 2020-2025 ($ millions)
Figure 51. Brazil Bioengineered Protein Drugs Revenue Growth 2020-2025 ($ millions)
Figure 52. APAC Bioengineered Protein Drugs Sales Market Share by Region in 2025
Figure 53. APAC Bioengineered Protein Drugs Revenue Market Share by Region (2020-2025)
Figure 54. APAC Bioengineered Protein Drugs Sales Market Share by Type (2020-2025)
Figure 55. APAC Bioengineered Protein Drugs Sales Market Share by Application (2020-2025)
Figure 56. China Bioengineered Protein Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. Japan Bioengineered Protein Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. South Korea Bioengineered Protein Drugs Revenue Growth 2020-2025 ($ millions)
Figure 59. Southeast Asia Bioengineered Protein Drugs Revenue Growth 2020-2025 ($ millions)
Figure 60. India Bioengineered Protein Drugs Revenue Growth 2020-2025 ($ millions)
Figure 61. Australia Bioengineered Protein Drugs Revenue Growth 2020-2025 ($ millions)
Figure 62. China Taiwan Bioengineered Protein Drugs Revenue Growth 2020-2025 ($ millions)
Figure 63. Europe Bioengineered Protein Drugs Sales Market Share by Country in 2025
Figure 64. Europe Bioengineered Protein Drugs Revenue Market Share by Country (2020-2025)
Figure 65. Europe Bioengineered Protein Drugs Sales Market Share by Type (2020-2025)
Figure 66. Europe Bioengineered Protein Drugs Sales Market Share by Application (2020-2025)
Figure 67. Germany Bioengineered Protein Drugs Revenue Growth 2020-2025 ($ millions)
Figure 68. France Bioengineered Protein Drugs Revenue Growth 2020-2025 ($ millions)
Figure 69. UK Bioengineered Protein Drugs Revenue Growth 2020-2025 ($ millions)
Figure 70. Italy Bioengineered Protein Drugs Revenue Growth 2020-2025 ($ millions)
Figure 71. Russia Bioengineered Protein Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. Middle East & Africa Bioengineered Protein Drugs Sales Market Share by Country (2020-2025)
Figure 73. Middle East & Africa Bioengineered Protein Drugs Sales Market Share by Type (2020-2025)
Figure 74. Middle East & Africa Bioengineered Protein Drugs Sales Market Share by Application (2020-2025)
Figure 75. Egypt Bioengineered Protein Drugs Revenue Growth 2020-2025 ($ millions)
Figure 76. South Africa Bioengineered Protein Drugs Revenue Growth 2020-2025 ($ millions)
Figure 77. Israel Bioengineered Protein Drugs Revenue Growth 2020-2025 ($ millions)
Figure 78. Turkey Bioengineered Protein Drugs Revenue Growth 2020-2025 ($ millions)
Figure 79. GCC Countries Bioengineered Protein Drugs Revenue Growth 2020-2025 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs in 2025
Figure 81. Manufacturing Process Analysis of Bioengineered Protein Drugs
Figure 82. Industry Chain Structure of Bioengineered Protein Drugs
Figure 83. Channels of Distribution
Figure 84. Global Bioengineered Protein Drugs Sales Market Forecast by Region (2026-2031)
Figure 85. Global Bioengineered Protein Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 86. Global Bioengineered Protein Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 87. Global Bioengineered Protein Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 88. Global Bioengineered Protein Drugs Sales Market Share Forecast by Application (2026-2031)
Figure 89. Global Bioengineered Protein Drugs Revenue Market Share Forecast by Application (2026-2031)